MX2010008844A - Proceso para preparar derivados de piridona 226. - Google Patents
Proceso para preparar derivados de piridona 226.Info
- Publication number
- MX2010008844A MX2010008844A MX2010008844A MX2010008844A MX2010008844A MX 2010008844 A MX2010008844 A MX 2010008844A MX 2010008844 A MX2010008844 A MX 2010008844A MX 2010008844 A MX2010008844 A MX 2010008844A MX 2010008844 A MX2010008844 A MX 2010008844A
- Authority
- MX
- Mexico
- Prior art keywords
- route
- preparing
- pyridone derivatives
- formula
- preparing pyridone
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
- C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Una ruta para la preparación de un compuesto de fórmula (I), en donde X, R1, R2, R7, R8 y R9 son tal como se describen y definen en la especificación. Proceso de las etapas seguidas en la ruta e intermediarios nuevos preparados durante la ruta también son descritos y reivindicados. Los compuestos de fórmula (I) son utilizados en la elaboración de compuestos farmacéuticos, en particular, los inhibidores de MEK, útiles en el tratamiento de enfermedades hiperproliferativas como el cáncer y las enfermedades inflamatorias.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2758208P | 2008-02-11 | 2008-02-11 | |
PCT/GB2009/050124 WO2009101432A2 (en) | 2008-02-11 | 2009-02-09 | Process for preparing pyridone derivatives 226 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2010008844A true MX2010008844A (es) | 2010-09-07 |
Family
ID=40677907
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010008844A MX2010008844A (es) | 2008-02-11 | 2009-02-09 | Proceso para preparar derivados de piridona 226. |
Country Status (12)
Country | Link |
---|---|
US (1) | US20110015392A1 (es) |
EP (1) | EP2252588A2 (es) |
JP (1) | JP2011511784A (es) |
KR (1) | KR20100122921A (es) |
CN (1) | CN101939298A (es) |
AU (1) | AU2009213828A1 (es) |
BR (1) | BRPI0908782A2 (es) |
CA (1) | CA2713722A1 (es) |
IL (1) | IL207165A0 (es) |
MX (1) | MX2010008844A (es) |
RU (1) | RU2010137639A (es) |
WO (1) | WO2009101432A2 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101973936B (zh) * | 2010-09-28 | 2012-02-08 | 太原理工大学 | 一种吡啶酮衍生物的制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT392789B (de) * | 1985-01-23 | 1991-06-10 | Toyama Chemical Co Ltd | Verfahren zur herstellung von 1-substituierten aryl-1,4-dihydro-4-oxonaphthyridinderivaten |
US20020019527A1 (en) * | 2000-04-27 | 2002-02-14 | Wei-Bo Wang | Substituted phenyl farnesyltransferase inhibitors |
US7517994B2 (en) * | 2003-11-19 | 2009-04-14 | Array Biopharma Inc. | Heterocyclic inhibitors of MEK and methods of use thereof |
US7732616B2 (en) * | 2003-11-19 | 2010-06-08 | Array Biopharma Inc. | Dihydropyridine and dihydropyridazine derivatives as inhibitors of MEK and methods of use thereof |
-
2009
- 2009-02-09 BR BRPI0908782A patent/BRPI0908782A2/pt not_active IP Right Cessation
- 2009-02-09 WO PCT/GB2009/050124 patent/WO2009101432A2/en active Application Filing
- 2009-02-09 RU RU2010137639/04A patent/RU2010137639A/ru unknown
- 2009-02-09 MX MX2010008844A patent/MX2010008844A/es not_active Application Discontinuation
- 2009-02-09 JP JP2010545565A patent/JP2011511784A/ja active Pending
- 2009-02-09 AU AU2009213828A patent/AU2009213828A1/en not_active Abandoned
- 2009-02-09 KR KR1020107020333A patent/KR20100122921A/ko not_active Application Discontinuation
- 2009-02-09 CN CN2009801047125A patent/CN101939298A/zh active Pending
- 2009-02-09 EP EP09711340A patent/EP2252588A2/en not_active Withdrawn
- 2009-02-09 CA CA2713722A patent/CA2713722A1/en not_active Abandoned
-
2010
- 2010-07-22 IL IL207165A patent/IL207165A0/en unknown
- 2010-08-11 US US12/854,388 patent/US20110015392A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
BRPI0908782A2 (pt) | 2017-06-13 |
AU2009213828A1 (en) | 2009-08-20 |
CN101939298A (zh) | 2011-01-05 |
US20110015392A1 (en) | 2011-01-20 |
KR20100122921A (ko) | 2010-11-23 |
WO2009101432A3 (en) | 2009-10-22 |
WO2009101432A2 (en) | 2009-08-20 |
CA2713722A1 (en) | 2009-08-20 |
JP2011511784A (ja) | 2011-04-14 |
EP2252588A2 (en) | 2010-11-24 |
IL207165A0 (en) | 2010-12-30 |
RU2010137639A (ru) | 2012-03-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2015221439B2 (en) | Crystalline 6,7-unsaturated-7-carbamoyl morphinane derivative, and method for producing same | |
PH12015501585A1 (en) | Manufacturing process for pyrimidine derivatives | |
PT2178881E (pt) | Novos derivados de 6-triazolopiridazina-sulfanil benzotiazole e benzimidazole, seu método de preparação, sua aplicação como medicamentos, composições farmacêuticas e nova utilização como inibidores de met | |
MX2009010059A (es) | Derivados de quinolina para el tratamiento de enfermedades inflamatorias. | |
IN2014MN02106A (es) | ||
TW200628154A (en) | Organic compounds | |
MX342212B (es) | Inhibidores de neprilisina. | |
MX2012013274A (es) | Novedosos derivados de la pirimidina. | |
MX2009003257A (es) | Procedimiento para la sintesis de derivados de fenoxi diaminopirimidina. | |
CY1116885T1 (el) | Υποκατεστημενα παραγωγα κυκλοεξυλομεθυλιου | |
TN2012000248A1 (en) | Novel spiropiperidine compounds | |
TW200745066A (en) | Novel PTP1B inhibitors | |
MX2009003739A (es) | Derivados de hidrobenzamida como inhibidores de hsp90. | |
UA99787C2 (en) | Lactams as beta secretase inhibitors | |
SG179206A1 (en) | Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors | |
GEP20115166B (en) | 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS | |
MX355561B (es) | Proceso para hacer inhibidores de girasa y topoisomerasa iv. | |
EA200801893A1 (ru) | Производные тетрагидронафталина, способ их получения и их применение в качестве ингибиторов воспаления | |
CY1113914T1 (el) | Νεα παραγωγα διυδροϊνδολονων, μεθοδος παρασκευης τους και φαρμακευτικες συνθεσεις οι οποιες τα περιεχουν | |
EA201270302A1 (ru) | Безводные формы производных пиридина | |
NZ591837A (en) | Amino acid derivative | |
MX2010001512A (es) | Nuevo procedimiento de preparacion. | |
EA201001252A1 (ru) | Способ получения производных 3,6-дигидро-1,3,5-триазина | |
MX2010008844A (es) | Proceso para preparar derivados de piridona 226. | |
GEP20156350B (en) | New process for synthesis of ivabradine and their additional salts with pharmaceutically acceptable acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |